Bellevue Group AG
- SEC CIK
- 0001674546
- Latest filing
- Aug 14, 2026
Holdings in Q2 2026
Holdings as of Jun 30, 2026, filed Aug 14, 2026. Long positions only; changes compare share counts with Q1 2026.
- Positions
- 148
- −7 vs. Q1 2026
- Portfolio value
- $4.75B
- +$550.7M (+13.1%) vs. Q1 2026
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| AMGNAmgen Inc | Stock | 851,550 | $308.4M | 6.5% | +556,192+188.3% | Added | History |
| VRTXVertex Pharmaceuticals Inc | Stock | 578,634 | $287.4M | 6.0% | −103,274−15.1% | Reduced | History |
| ARGXArgenx SE | SPONSORED ADR | 301,000 | $279.3M | 5.9% | −12,000−3.8% | Reduced | History |
| GILDGilead Sciences, Inc. | Stock | 2,158,772 | $272.7M | 5.7% | +988,893+84.5% | Added | History |
| RVMDRevolution Medicines, Inc. | COM | 1,048,014 | $196.3M | 4.1% | −496,442−32.1% | Reduced | History |
| ORKAOruka Therapeutics, Inc. | COM | 1,657,190 | $157.7M | 3.3% | +1,150,182+226.9% | Added | History |
| INSMINSMED Inc | COM PAR $.01 | 1,393,418 | $148.6M | 3.1% | +1,383,384+13,787.0% | Added | History |
| SRRKScholar Rock Holding Corp | COM | 2,449,547 | $134.7M | 2.8% | −1,135,026−31.7% | Reduced | History |
| NUVLNuvalent, Inc. | COM | 1,053,268 | $130.1M | 2.7% | 00.0% | Unchanged | History |
| VRDNViridian Therapeutics, Inc. | COM | 6,731,909 | $123.7M | 2.6% | +5,765+0.1% | Added | History |
| RLAYRelay Therapeutics, Inc. | COM | 6,185,970 | $115.7M | 2.4% | −1,609,272−20.6% | Reduced | History |
| PCVXVaxcyte, Inc. | COM | 1,971,935 | $114.6M | 2.4% | +781,238+65.6% | Added | History |
| UTHRUnited Therapeutics Corp | COM | 188,515 | $102.1M | 2.1% | +186,438+8,976.3% | Added | History |
| ISRGIntuitive Surgical Inc | COM NEW | 254,809 | $101.3M | 2.1% | −31,845−11.1% | Reduced | History |
| REGNRegeneron Pharmaceuticals, Inc. | COM | 157,291 | $98.1M | 2.1% | −121,383−43.6% | Reduced | History |
| CRNXCrinetics Pharmaceuticals, Inc. | COM | 2,620,000 | $98.0M | 2.1% | −660,000−20.1% | Reduced | History |
| BBIOBridgeBio Pharma, Inc. | COM | 1,189,506 | $88.6M | 1.9% | +1,164,129+4,587.3% | Added | History |
| IMCRImmunocore Holdings plc | ADS | 2,788,245 | $88.5M | 1.9% | −8,558−0.3% | Reduced | History |
| ABTAbbott Laboratories | Stock | 947,115 | $85.9M | 1.8% | −204,520−17.8% | Reduced | History |
| SYKStryker Corp | Stock | 268,461 | $84.5M | 1.8% | +51,224+23.6% | Added | History |
| MDTMedtronic plc | Stock | 994,233 | $77.8M | 1.6% | +36,904+3.9% | Added | History |
| IONSIonis Pharmaceuticals Inc | COM | 972,258 | $77.1M | 1.6% | −846,407−46.5% | Reduced | History |
| ELVNEnliven Therapeutics, Inc. | COM | 1,490,000 | $75.6M | 1.6% | −830,867−35.8% | Reduced | History |
| VERAVera Therapeutics, Inc. | CL A | 1,710,808 | $73.4M | 1.5% | +370.0% | Added | History |
| JBIOJade Biosciences, Inc. | COM NEW | 3,057,996 | $67.9M | 1.4% | −443,506−12.7% | Reduced | History |
| EWEdwards Lifesciences Corp | Stock | 739,234 | $66.9M | 1.4% | −100,217−11.9% | Reduced | History |
| RAREUltragenyx Pharmaceutical Inc. | COM | 1,982,775 | $66.2M | 1.4% | −397,225−16.7% | Reduced | History |
| UNHUnitedHealth Group Inc | Stock | 149,127 | $62.0M | 1.3% | +924+0.6% | Added | History |
| DXCMDexcom Inc | COM | 822,489 | $55.4M | 1.2% | +33,723+4.3% | Added | History |
| CLDXCelldex Therapeutics, Inc. | COM NEW | 1,200,000 | $44.7M | 0.9% | 00.0% | Unchanged | History |
| AVLNAvalyn Pharma Inc. | COM SHS | 1,350,000 | $44.4M | 0.9% | +1,350,000 | New | History |
| DMRADamora Therapeutics, Inc. | COM NEW | 1,618,846 | $42.1M | 0.9% | −679,154−29.6% | Reduced | History |
| IRONDisc Medicine, Inc. | COM | 560,000 | $41.0M | 0.9% | +100,686+21.9% | Added | History |
| TMOThermo Fisher Scientific Inc. | Stock | 79,816 | $40.0M | 0.8% | +15,404+23.9% | Added | History |
| BSXBoston Scientific Corp | Stock | 887,650 | $37.9M | 0.8% | −579,244−39.5% | Reduced | History |
| LLYEli Lilly & Co | Stock | 29,882 | $35.8M | 0.8% | −4,050−11.9% | Reduced | History |
| CGONCG Oncology, Inc. | COM | 493,596 | $35.1M | 0.7% | +493,596 | New | History |
| IDXXIDEXX Laboratories Inc | COM | 61,780 | $32.5M | 0.7% | −27,351−30.7% | Reduced | History |
| RMDResmed Inc | COM | 148,195 | $28.9M | 0.6% | −11,151−7.0% | Reduced | History |
| KRYSKrystal Biotech, Inc. | COM | 77,530 | $28.8M | 0.6% | −404,255−83.9% | Reduced | History |
| GLUEMonte Rosa Therapeutics, Inc. | COM | 1,190,000 | $28.8M | 0.6% | −60,000−4.8% | Reduced | History |
| DHRDanaher Corp | Stock | 143,844 | $27.4M | 0.6% | −58,320−28.8% | Reduced | History |
| JNJJohnson & Johnson | Stock | 103,280 | $26.2M | 0.6% | −15,822−13.3% | Reduced | History |
| SPTXSeaport Therapeutics, Inc. | COMMON STOCK | 1,100,000 | $23.9M | 0.5% | +1,100,000 | New | History |
| PVLAPalvella Therapeutics, Inc. | COM | 155,000 | $23.7M | 0.5% | +155,000 | New | History |
| ALGNAlign Technology Inc | COM | 139,680 | $23.6M | 0.5% | 00.0% | Unchanged | History |
| ANNXAnnexon, Inc. | COM | 4,100,016 | $23.4M | 0.5% | −1,057,274−20.5% | Reduced | History |
| HUMHumana Inc | Stock | 58,398 | $23.2M | 0.5% | −6,100−9.5% | Reduced | History |
| ELVElevance Health, Inc. | Stock | 56,449 | $21.8M | 0.5% | +3,931+7.5% | Added | History |
| TNGXTango Therapeutics, Inc. | COM | 694,182 | $21.7M | 0.5% | −1,705,818−71.1% | Reduced | History |
| STESTERIS plc | SHS USD | 99,877 | $21.0M | 0.4% | −10.0% | Reduced | History |
| SYRESpyre Therapeutics, Inc. | COM NEW | 229,931 | $20.4M | 0.4% | +229,931 | New | History |
| COAGHemab Therapeutics Holdings, Inc. | COM SHS | 550,000 | $20.2M | 0.4% | +550,000 | New | History |
| PODDInsulet Corp | Stock | 127,498 | $19.4M | 0.4% | −36,158−22.1% | Reduced | History |
| CICigna Group | Stock | 66,500 | $18.3M | 0.4% | −31,763−32.3% | Reduced | History |
| GKOSGLAUKOS Corp | COM | 128,667 | $18.0M | 0.4% | −17,036−11.7% | Reduced | History |
| CVSCVS Health Corp | Stock | 169,366 | $17.5M | 0.4% | +80,003+89.5% | Added | History |
| BDXBecton Dickinson & Co | Stock | 109,729 | $16.6M | 0.3% | −12,158−10.0% | Reduced | History |
| GEHCGE HealthCare Technologies Inc. | Stock | 252,744 | $16.2M | 0.3% | −164,143−39.4% | Reduced | History |
| LIVNLivaNova PLC | SHS | 195,621 | $16.1M | 0.3% | +9,436+5.1% | Added | History |
| CNCCentene Corp | Stock | 228,865 | $14.7M | 0.3% | −32,201−12.3% | Reduced | History |
| MRKMerck & Co., Inc. | Stock | 113,061 | $14.5M | 0.3% | −93,530−45.3% | Reduced | History |
| COOCooper Companies, Inc. | COM | 197,135 | $14.1M | 0.3% | −75,049−27.6% | Reduced | History |
| PBLSParabilis Medicines, Inc. | Stock | 500,000 | $13.7M | 0.3% | +500,000 | New | History |
| TEVATeva Pharmaceutical Industries Ltd | SPONSORED ADS | 345,899 | $11.7M | 0.2% | +95,817+38.3% | Added | History |
| GMEDGlobus Medical Inc | Stock | 146,108 | $11.5M | 0.2% | −101,153−40.9% | Reduced | History |
| PRCTPROCEPT BioRobotics Corp | COM | 502,286 | $11.3M | 0.2% | 00.0% | Unchanged | History |
| ZBHZimmer Biomet Holdings, Inc. | Stock | 126,707 | $10.9M | 0.2% | −28,864−18.6% | Reduced | History |
| VEEVVeeva Systems Inc | Stock | 59,347 | $10.5M | 0.2% | +2,830+5.0% | Added | History |
| ABBVAbbVie Inc. | Stock | 40,476 | $10.2M | 0.2% | −53,091−56.7% | Reduced | History |
| TXG10x Genomics, Inc. | CL A COM | 261,470 | $10.0M | 0.2% | −68,022−20.6% | Reduced | History |
| HCAHCA Healthcare, Inc. | COM | 23,750 | $9.26M | 0.2% | −14,015−37.1% | Reduced | History |
| AURAAura Biosciences, Inc. | COM | 1,166,667 | $8.28M | 0.2% | +1,166,667 | New | History |
| MCKMcKesson Corp | Stock | 9,625 | $7.27M | 0.2% | −12,727−56.9% | Reduced | History |
| THCTenet Healthcare Corp | COM NEW | 38,868 | $7.27M | 0.2% | +599+1.6% | Added | History |
| PTGXProtagonist Therapeutics, Inc | COM | 55,682 | $6.83M | 0.1% | +41,235+285.4% | Added | History |
| NTRANatera, Inc. | COM | 24,806 | $6.73M | 0.1% | −6,888−21.7% | Reduced | History |
| TMDXTransMedics Group, Inc. | COM | 101,139 | $6.72M | 0.1% | 00.0% | Unchanged | History |
| MOHMolina Healthcare, Inc. | COM | 27,761 | $6.35M | 0.1% | +27,761 | New | History |
| ALKSAlkermes plc. | SHS | 120,243 | $6.30M | 0.1% | +111,373+1,255.6% | Added | History |
| RPRXRoyalty Pharma plc | SHS CLASS A | 112,311 | $6.30M | 0.1% | +74,015+193.3% | Added | History |
| WAYWaystar Holding Corp. | COM | 293,592 | $6.03M | 0.1% | +37,453+14.6% | Added | History |
| PRVAPrivia Health Group, Inc. | COM | 226,703 | $5.83M | 0.1% | 00.0% | Unchanged | History |
| GMRSGMR Solutions Inc. | COM CL A | 333,333 | $5.15M | 0.1% | +333,333 | New | History |
| NBIXNeurocrine Biosciences Inc | Stock | 24,037 | $4.05M | 0.1% | +19,391+417.4% | Added | History |
| OMDAOmada Health, Inc. | COM | 157,938 | $3.47M | 0.1% | 00.0% | Unchanged | History |
| KMTSKestra Medical Technologies, Ltd. | SHS | 129,215 | $3.29M | 0.1% | +13,625+11.8% | Added | History |
| MDLNMedline Inc. | COM CL A | 82,153 | $3.24M | 0.1% | −54,482−39.9% | Reduced | History |
| ILMNIllumina, Inc. | COM | 18,134 | $3.19M | 0.1% | −2,089−10.3% | Reduced | History |
| ONCBeOne Medicines Ltd. | ADR | 10,474 | $2.98M | 0.1% | +6,662+174.8% | Added | History |
| NAMSNewAmsterdam Pharma Co N.V. | ORDINARY SHARES | 86,994 | $2.95M | 0.1% | +59,333+214.5% | Added | History |
| MDGLMadrigal Pharmaceuticals, Inc. | COM | 4,675 | $2.51M | 0.1% | +1,635+53.8% | Added | History |
| SPYSPDR S&P 500 ETF Trust | ETF | 2,700 | $2.02M | <0.1% | 00.0% | Unchanged | History |
| BNTXBioNTech SE | SPONSORED ADS | 21,229 | $1.98M | <0.1% | +378+1.8% | Added | History |
| ADPTAdaptive Biotechnologies Corp | COM | 89,439 | $1.92M | <0.1% | +13,258+17.4% | Added | History |
| CYTKCytokinetics Inc | COM NEW | 19,007 | $1.62M | <0.1% | +10,166+115.0% | Added | History |
| ALMRAlamar Biosciences, Inc. | COMMON STOCK | 55,738 | $1.51M | <0.1% | +55,738 | New | History |
| PHRPhreesia, Inc. | COM | 140,495 | $1.45M | <0.1% | +9,503+7.3% | Added | History |
| MOBIMobia Medical, Inc. | COMMON STOCK | 100,000 | $1.34M | <0.1% | +100,000 | New | History |
| BLLNBillionToOne, Inc. | CL A | 10,554 | $1.27M | <0.1% | 00.0% | Unchanged | History |
Sold out since Q1 2026 (24)
Positions held at the end of Q1 2026 that are gone from this filing.
| Security | Class | Shares in Q1 2026 | Value in Q1 2026 | % of portfolio in Q1 2026 | History |
|---|---|---|---|---|---|
| EWTXEdgewise Therapeutics, Inc. | COM | 1,528,518 | $48.1M | 1.1% | History |
| INSPInspire Medical Systems, Inc. | COM | 99,735 | $5.14M | 0.1% | History |
| PENPenumbra Inc | COM | 12,267 | $4.03M | 0.1% | History |
| RNAAtrium Therapeutics, Inc. | COM | 263,096 | $3.52M | 0.1% | History |
| MASIMasimo Corp | COM | 8,753 | $1.56M | <0.1% | History |
| EQNREquinor ASA | SPONSORED ADR | 17,573 | $741.6K | <0.1% | History |
| XOMExxonMobil Holdings Corp | COM | 4,370 | $741.4K | <0.1% | History |
| BPBP PLC | ADR | 15,644 | $735.3K | <0.1% | History |
| SHELShell plc | ADR | 7,844 | $729.5K | <0.1% | History |
| CSCOCisco Systems, Inc. | Stock | 8,000 | $620.7K | <0.1% | History |
| BABAAlibaba Group Holding Ltd | ADR | 4,700 | $589.7K | <0.1% | History |
| PGProcter & Gamble Co | Stock | 3,900 | $563.3K | <0.1% | History |
| MAMastercard Inc | Stock | 1,100 | $549.6K | <0.1% | History |
| BLKBlackRock, Inc. | Stock | 450 | $432.8K | <0.1% | History |
| VVisa Inc. | Stock | 1,400 | $423.1K | <0.1% | History |
| CNTACentessa Pharmaceuticals plc | SPONSORED ADS | 9,030 | $358.7K | <0.1% | History |
| JDJD.com, Inc. | SPON ADS CL A | 11,000 | $325.3K | <0.1% | History |
| ACNAccenture plc | Stock | 1,500 | $297.4K | <0.1% | History |
| ADBEAdobe Inc. | Stock | 1,200 | $291.7K | <0.1% | History |
| OLMAOlema Pharmaceuticals, Inc. | COM | 16,443 | $245.2K | <0.1% | History |
| ASNDAscendis Pharma A/S | SPONSORED ADR | 536 | $122.6K | <0.1% | History |
| BBOTBridgeBio Oncology Therapeutics, Inc. | COM NEW | 6,982 | $62.5K | <0.1% | History |
| WVEWave Life Sciences, Inc. | SHS | 5,261 | $38.1K | <0.1% | History |
| QGENQiagen N.V. | ORD SHARES | 243 | $9.73K | <0.1% | History |